Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: A Vaccine Trial for Low Grade Gliomas [Phase 2]

View source ↗

Summary

Phase 2 vaccine trial for low-grade glioma is currently recruiting, per ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: James Felker | Conditions: Low Grade Glioma | Phase 2 | Status: RECRUITING